Autologous Gene Editing for Sickle Cell Disease and Transfusion Dependent Beta Thalassemia

The Advanced Practice Providers SIG hosted a webinar on 'Autologous Gene Editing for Sickle Cell Disease and Transfusion Dependent Beta Thalassemia' on Thursday, July 18, at 2 p.m. CDT. This webinar is open to all ASTCT members and non-members. Please note that there is no CME offered for attending this webinar. 

Speaker:

Haydar Frangoul, MD, MS; Program Director, Sarah Cannon Pediatric Hematology/Oncology & Cellular Therapy @TriStar Centennial

Session Learning Objectives:

• Understand importance of elevated fetal hemoglobin in SCD and TDT
• Review gene editing technology to induce fetal hemoglobin
• Review gene therapy patient journey
• Understand indications for gene editing in SCD and TDT
• Review the updated results for gene therapy  
• Understand toxicities related to gene editing therapy